ETHSX Fees and Costs — Eaton Vance Worldwide Health Sciences Fund, Class A
Data updated: 2026-07-27
The net expense ratio is 1.18%: a 0.80% management fee, a 0.25% 12b-1 fee plus 0.15% other expenses, less a 0.03% fee waiver. This share class carries a maximum front-end sales load of 5.25%. In fiscal 2025 the fund paid $113K in broker commissions, 0.0119% of average net assets, and portfolio turnover was 30%.
ETHSX Fees and Expenses
Annual operating expenses and sales charges of ETHSX. Prospectus, as of August 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.80% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.15% |
| Gross expense ratio | 1.21% |
| Fee waiver | −0.03% |
| Net expense ratio | 1.18% |
| Sales charges | |
|---|---|
| Max front load | 5.25% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
ETHSX Costs Over Time
On $10,000 invested in ETHSX, assuming 5% a year before costs, total costs come to $1,374 over 5 years, cutting the return by 2.36% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $525 | $525 | $525 |
| Fund expenses (net expense ratio 1.18%) | $117 | $366 | $633 |
| Trading costs (broker commissions) | $1 | $4 | $6 |
| Lost growth on money paid in costs | $26 | $101 | $210 |
| Total costs | $670 | $995 | $1,374 |
| Value after costs | $9,830 | $10,581 | $11,389 |
| Impact on return, per year | 6.70% | 3.10% | 2.36% |
ETHSX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0119%
- Total broker commissions: $113K
- Bought from dealers (principal trades, not a cost): $221.3M
- Portfolio turnover (prospectus): 30%
- Securities on loan, average value: $4.2M
- Net income from securities lending: $46K (0.005% of average net assets)
ETHSX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| UBS Securities LLC | $26K | 26.98% |
| Citigroup Global Markets Inc. | $13K | 13.76% |
| SG Americas Securities, LLC | $11K | 11.17% |
| RBC Capital Markets, LLC | $11K | 10.89% |
| Stifel, Nicolaus & Company, Incorporated | $8K | 8.38% |
| Cowen and Company, LLC | $7K | 6.92% |
| Jefferies LLC | $7K | 6.72% |
| J.P. Morgan Securities LLC | $6K | 5.96% |
| Nomura Securities International, Inc. | $5K | 5.46% |
| BofA Securities, Inc. | $4K | 3.76% |
ETHSX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| State Street Global Markets, LLC | $216.6M | 97.90% |
| J.P. Morgan Securities LLC | $4.6M | 2.10% |
Eaton Vance Worldwide Health Sciences Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| EIHSX | Class I | 0.93% | none |
| ETHSX | Class A | 1.18% | 5.25% |
| ERHSX | Class R | 1.43% | none |
| ECHSX | Class C | 1.93% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.